12/18: Multi-week swing thesis based on strong daily base and post-FDA-news accumulation. Price is consolidating above heavy volume with rising daily structure, suggesting absorption rather than distribution. $1 compliance dynamics and strong cash position add tailwinds. Entry ~0.87, risk defined at loss of LOD (~0.82–0.83). Targets 1.00–1.05 initially, with potential extension toward 1.20+ if daily trend holds. Trade is managed on daily structure, not intraday noise. Exit: had to cut this trade

Entry comments: Not a fan of FEMY but seems it wants $1 after recent high and now above 5 NOV ZXGPT entry of above $.78 and target of $97. Was on RB scanner and reco by JW. He got in at $95.5 and thinks could run. Recent high of $1.11 I might target $1.04 area for overnight. It got to $.967 today so should have closed out for profit instead of holding.

Exit comments: Was up to $.96 pre market. Had a sell in over weekend for $.98 Didn't get that high. It kept bouncing between $.90 and $.92 when I saw it for a couple hours decided to cut it. Sold 1500 shares at $.925 and 1500 at $.92 for a total of $2767.51 for $.9225 a share

11/7: buying this MDBO, has 1 USD hold also all written over it. Going to add if it dips to .90s again. Risk .89. Possible gapper for Monday on MDBO. No gap, sell pre market for small loss. Entry wasn't ideal, should have been below 1 USD in afterhours.

Breakout

Scalp

watch more video

Bought looking for a mdbo over $0.9. Got stuffed, should have cut but got stubborn and gave it time. Broke risk, cut.

11/5: Restab on MDBO play, risking .73, goal 1 - 1.2 - 1.5, if it can get some more volume. Cut in afterhours, not swinging this.

11/5: taking some on MDBO play. Risking .75 and stopped out